Beijing SL Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 296.58 million compared to CNY 274.55 million a year ago. Revenue was CNY 296.58 million compared to CNY 274.55 million a year ago.

Net income was CNY 201.93 million compared to CNY 63.3 million a year ago. Basic earnings per share from continuing operations was CNY 0.2 compared to CNY 0.06 a year ago. Diluted earnings per share from continuing operations was CNY 0.2 compared to CNY 0.06 a year ago.